Shandong Jincheng Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 52.7% in First Quarter of 2023
Listen to the full version

Shandong Jincheng Pharmaceutical Group Co.,Ltd. (山东金城医药集团股份有限公司) (300233.SZ) reported a net profit of 54.9 million yuan in the first quarter of 2023, down 52.7% year-on-year.
Meanwhile, the company posted 829.5 million yuan in revenue, down 13% year-on-year.
At the end of the reporting period, it had 5.9 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 36.7%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR